Objective Adiposity is prevalent among patients with psoriatic arthritis (PsA). However, the
temporal relation is unclear. The present study was undertaken to investigate whether …

Background Obesity is associated with an increased risk of psoriasis; however, its potential
impact on the risk of psoriatic arthritis (PsA) remains unclear. Objectives To evaluate the …

Objectives Both overall and central obesity have been associated with the risk of psoriasis in
a prospective study. Data on the association between obesity and psoriatic arthritis (PsA) …

Introduction/objectives Assuming that there is a link between lipid and glucose metabolism
and inflammation in patients with psoriatic arthritis (PsA), our aim was to evaluate the …

Objectives To determine the independent association of central adiposity, assessed by waist
circumference, with odds of psoriasis, PsA and RA prevalence after controlling for general …

Summary Background Psoriatic arthritis (PsA) is a progressive and often destructive joint
disease affecting approximately 20% of people with psoriasis. Objectives To investigate …

Objective We compared the prevalence and the clustering of the metabolic syndrome (MetS)
components (obese body mass index [BMI;≥ 30 kg/m2], hypertriglyceridemia, low high …

Objective The aim of this study was to investigate the prevalence of comorbidities and
cardiovascular (CV) risk factors (RFs) in treatment‐naive patients with early psoriatic arthritis …

Objectives: We aimed to determine the prevalence of cardiovascular risk factors in patients
with psoriatic arthritis (PsA) followed at a large Swedish Rheumatology Clinic, and to …

PsA is an axial and/or peripheral inflammatory arthritis associated with psoriasis, included in
the group of spondylarthritides. It has been suggested that PsA could be a systemic disease …